The study, led by Kaiyuan Cen of Guidong People’s Hospital of Guangxi Zhuang Autonomous Region and Zhuoqiao He of the First Affiliated Hospital of Shantou University Medical College, was a single-centre retrospective cohort study of adults hospitalized with chronic heart failure between 31 May 2023 and 31 May 2024, with follow-up data locked on 31 May 2025. Of 201 patients screened, 160 met the inclusion criteria, and the clinical stakes of the exercise were immediately apparent: 68 of those 160 patients—42.5 per cent—experienced a major adverse cardiovascular event, or MACE, within a year of their index hospitalization. That figure underscores a persistent problem in cardiology. Chronic heart failure remains a condition of high and unevenly distributed risk, and the field has long lacked tools that can reliably separate the patient who will be readmitted or die within months from the one who will remain stable on guideline-directed therapy.

The technical core of the new approach lies in the transformation of the conventional 12-lead ECG into a vectorcardiogram using the Kors method, a well-established mathematical technique that reconstructs the heart’s electrical dipole as a rotating vector in three-dimensional space. Rather than viewing the heart’s depolarization and repolarization through the fixed projections of twelve surface electrodes, the vectorcardiogram traces the path of the cardiac electrical axis as a loop in the frontal, horizontal, and sagittal planes. From this reconstruction, the researchers extracted features that are difficult or impossible to appreciate on a standard tracing: the spatial angles between the QRS complex, which represents ventricular depolarization, and the T wave, which represents repolarization. Discordance between these two processes—measured as a wide QRS–T angle in any plane—is thought to reflect abnormal ventricular conduction and repolarization heterogeneity, electrophysiological substrate that has been linked in prior studies to arrhythmic death and adverse remodelling.

The prespecified primary model was deliberately parsimonious, incorporating just six predictors: left ventricular end-diastolic diameter (LVEDD) measured by echocardiography, New York Heart Association functional class, the frontal, horizontal, and sagittal QRS–T angles, and a binary morphological feature known as the QRS-loop reversal/U-turn sign. The latter is a qualitative abnormality in which the ventricular depolarization loop reverses its direction of rotation or executes a U-shaped turn, signalling aberrant conduction pathways. Notably, the investigators evaluated whether two of the most celebrated markers in heart failure prognostication—brain natriuretic peptide (BNP) and left ventricular ejection fraction (LVEF)—added value beyond the six-predictor set, embedding them in full-model, comparator-model, and incremental-value analyses. Because the prediction target was a fixed 12-month probability rather than a time-to-event hazard, the team used multivariable logistic regression as the primary modelling framework, an appropriate choice for a binary endpoint observed over a uniform window.

The performance figures reported in the paper are striking. The six-predictor model produced an apparent AUC of 0.946, with a 95 per cent confidence interval of 0.914 to 0.978. Recognizing that apparent performance on the development dataset invariably overstates true predictive ability, the researchers subjected the model to bootstrap internal validation using 1,000 resamples. This procedure yielded an AUC optimism estimate of just 0.012, leaving an optimism-corrected AUC of 0.934. Calibration was assessed with equal rigour: the apparent Brier score of 0.091 rose modestly to 0.106 after bootstrap correction, calibration-in-the-large was −0.009, and the calibration slope was corrected from a perfect 1.000 to 0.852, with the same uniform shrinkage factor applied to the model’s coefficients to guard against overfitting in future applications. A shrinking factor of 0.852 means each predictor’s coefficient is tempered by roughly fifteen per cent, a standard penalty that trades a small loss in apparent fit for improved generalizability.

Perhaps the most clinically persuasive result came from the incremental-value analyses. When the VCG-derived features were added to a conventional base model built on standard clinical predictors, the AUC rose from 0.890 to 0.955—a difference of 0.065 that reached statistical significance at DeLong P = 0.001. The augmented model also achieved a lower Brier score and favourable discrimination and reclassification indices, indicating that it did not merely rank patients differently but genuinely moved them into more accurate risk categories. Decision-curve analysis, a method that evaluates the net clinical benefit of a model across a range of risk thresholds, suggested that the VCG-augmented approach would deliver higher net benefit than selected single-marker comparators within the development cohort. In practical terms, this means that at most clinically meaningful threshold probabilities, acting on the model’s predictions would identify more true events and generate fewer false alarms than relying on any single conventional marker alone.

The biological rationale for why these VCG features carry such prognostic weight is grounded in decades of electrophysiological research. Prior work has demonstrated that a wide spatial QRS–T angle predicts cardiac death in the general population, that the frontal QRS–T angle predicts increased morbidity and mortality in chronic heart failure, and that vectorcardiographic findings are associated with recurrent ventricular arrhythmias in patients with implantable cardioverter-defibrillators. The QRS–T angle quantifies the degree of spatial discordance between the sequence of ventricular activation and the sequence of recovery—discordance that widens as conduction disease, ischaemia, and structural remodelling accumulate in the failing myocardium. The QRS-loop reversal/U-turn sign adds morphological information about the activation pathway itself, capturing abnormalities such as conduction delay and scar-related altered depolarization that angle measures alone may miss. Together with echocardiographic ventricular dimensions and symptomatic status, these features sketch a compact portrait of both the structure and the electrophysiology of the failing heart.

The authors are careful, appropriately so, to frame the work as a development and internal validation study rather than a demonstration of clinical readiness. Internal validation by bootstrap quantifies how much a model’s apparent performance is inflated by overfitting to its own data, but it cannot address the questions that matter most before deployment: whether the model generalizes to patients from different hospitals, ethnic backgrounds, and health systems; whether ECG acquisition and processing pipelines elsewhere would yield comparable VCG reconstructions; and whether clinicians acting on the model’s outputs would genuinely alter management in ways that improve outcomes. The de-identified analytic dataset cannot be made publicly available owing to institutional privacy requirements, though statistical code and data excerpts are available from the corresponding author on reasonable request. The study received no external funding, was approved by the Ethics Committee of Guidong People’s Hospital under approval number GDKY202590, and the authors declare no competing interests.

Even so, the appeal of the approach is hard to overstate. It requires no new hardware, no additional blood draws, and no expensive imaging: the raw material is a routine ECG already recorded for virtually every hospitalized heart failure patient, and the transformation to a vectorcardiogram is a computational step that can be automated in seconds. In an era when deep learning models have shown that ECG voltage data alone can predict mortality, the present work occupies a complementary middle ground—using interpretable, physiologically grounded features extracted from the same inexpensive signal, within a transparent logistic regression framework whose coefficients clinicians can inspect rather than a black box they must trust blindly. Each of the six predictors maps onto a familiar clinical concept: ventricular size, symptom severity, ventricular conduction, and repolarization geometry.

The study team, which also included Hong Chen of the University of Tsukuba, Yi Tan of Guidong People’s Hospital, Lixia Lin of Guangxi University of Chinese Medicine, and Xiaojuan Xu of Tongji University, emphasizes that external multicentre validation is required before any clinical implementation. That caveat is the correct one, and it sets the agenda for the next stage of this line of research. If the 0.934 optimism-corrected AUC survives contact with independent cohorts, heart failure teams could gain a near-zero-cost decision support tool for flagging the roughly four in ten hospitalized patients who face a major cardiovascular event within a year—enabling intensified follow-up, earlier escalation of therapy, and closer surveillance of the patients whose electrical signatures betray a heart in the greatest danger.

The study, published in the Journal of the American Medical Informatics Association, analysed the health records of 12,701 UK Biobank participants who had experienced an acute myocardial infarction. Rather than examining only whether patients suffered another heart event, the research team tracked the sequence and timing of diagnoses recorded after the initial heart attack. This allowed the investigators to study multimorbidity as a dynamic process: not simply how many conditions a person developed, but which conditions appeared, when they emerged and how they clustered together.

To find these patterns, the team applied data-driven temporal machine learning. Conventional clinical risk scores generally combine measurements such as age, blood pressure, cholesterol and medical history to estimate the likelihood of a future event. Temporal machine learning takes a different approach by analysing the order and timing of events. In this study, the method grouped patients whose post-heart-attack diagnoses followed similar trajectories, revealing three broad health pathways that might otherwise have remained hidden in standard statistical analyses.

The largest trajectory included approximately 63 per cent of the patients. People in this group tended to develop cardiometabolic conditions, including hypertension, type 2 diabetes and dyslipidaemia, alongside episodic heart and respiratory complications. These disorders are biologically interconnected: high blood pressure can place additional strain on the heart and blood vessels, insulin resistance can promote vascular damage, and abnormal blood lipid levels can accelerate atherosclerosis. The combination may create a cycle in which metabolic dysfunction increases cardiovascular stress while recurrent illness further reduces physical resilience.

A second trajectory involved around 23 per cent of the participants and was associated with deterioration affecting the lungs, musculoskeletal system and other organs. The researchers describe this as a group thought to be characterised by smoking-related risk. Smoking can damage the respiratory system directly, but its effects extend far beyond the lungs. Tobacco exposure contributes to chronic inflammation, impaired blood-vessel function, reduced oxygen delivery and accelerated tissue degeneration. These processes may help explain why patients in this trajectory experienced a wider decline involving respiratory and musculoskeletal health rather than a narrowly cardiac pattern.

The third trajectory, representing approximately 14 per cent of the cohort, was marked by structural heart disease, arrhythmias and kidney problems. Structural changes can interfere with the heart’s ability to pump efficiently, while arrhythmias disrupt its electrical rhythm. Kidney dysfunction is closely linked to cardiovascular disease through fluid regulation, blood pressure control and vascular injury. When heart and kidney problems develop together, each can intensify the other, producing a clinically complex condition that may require coordinated monitoring across several medical specialties.

Mortality differed sharply between the trajectories. The smoking-related group had a mortality rate of 44 per cent, more than three times the rate observed in the largest group dominated by cardiometabolic conditions. The contrast indicates that a patient’s future risk may depend not only on the presence of disease, but also on the type of biological pathway that follows the initial heart attack. Respiratory illness, older age and higher levels of socioeconomic deprivation were among the strongest predictors of membership in the highest-risk trajectory, according to the researchers.

Dr Anthony Onoja, the study’s lead author and a research fellow at the University of Surrey, said the analysis showed that a patient’s likely trajectory could be predicted at the time of the heart attack using pre-existing diagnoses and demographic information. The model was particularly effective at identifying people most likely to enter the high-risk pathway. Such a system could eventually be integrated into hospital records to flag patients who may need intensive respiratory assessment, smoking-cessation support, rehabilitation or closer monitoring for complications outside the heart. The researchers emphasise, however, that the approach remains at an early stage and would need further validation before routine clinical use.

The team also investigated whether the statistical groups reflected meaningful biological differences rather than merely being artefacts of medical-record patterns. Genetic analysis found that each trajectory was associated with distinct molecular pathways. The largest cardiometabolic group was linked to immune activation and tissue remodelling, processes involved in inflammation and the repair or restructuring of damaged organs. The trajectory involving structural heart disease, arrhythmias and kidney problems was associated with insulin signalling and lipid transport, biological systems that influence energy use and cardiovascular metabolism. The smoking-related trajectory showed links to chronic inflammation and degeneration, consistent with the long-term effects of tobacco exposure and systemic tissue injury.

The researchers compared the machine-learning trajectories with established clinical tools, including the SMART score, which is used to estimate the likelihood of future cardiovascular events. Professor Nophar Geifman, senior author of the study, said conventional risk assessments remained the strongest single predictor of mortality in the analysis. However, the trajectories added information that a single risk score cannot provide. A score may indicate that a patient is at high risk, while a trajectory can suggest whether that risk is more likely to involve metabolic disease, rhythm and kidney complications, or widespread respiratory and organ decline. That distinction could help clinicians move from general risk estimation toward earlier, targeted intervention.

The findings offer a new way to think about recovery after myocardial infarction, treating it as a long-term sequence of interconnected health events rather than an isolated cardiac emergency. The approach could support more personalised surveillance by helping healthcare teams identify which organs and disease processes are most likely to require attention. At the same time, the study does not establish that the machine-learning patterns cause the observed outcomes, and the trajectories will need to be tested in other populations and healthcare systems. If the results are confirmed, temporal models could become a powerful complement to existing risk scores, transforming routinely collected medical records into an early-warning system for the diverse paths heart attack survivors may follow.

Subject of Research: Health trajectories and multimorbidity after acute myocardial infarction

Article Title: Explainable temporal machine learning of multimorbidity trajectories after acute myocardial infarction: complementing clinical risk scores with mechanistic phenotypes

News Publication Date: 6-Aug-2026

Web References: https://doi.org/10.1093/jamia/ocag135

References: Journal of the American Medical Informatics Association, DOI: 10.1093/jamia/ocag135

Keywords

heart attack, myocardial infarction, cardiovascular disease, machine learning, artificial intelligence, multimorbidity, cardiometabolic disease, arrhythmia, kidney disease, respiratory disease, health trajectories, precision medicine, UK Biobank

Leading the charge, Dr. Neal Chatterjee and his team at the University of Washington School of Medicine have harnessed the combined power of machine learning and clinical data to create predictive models that could potentially alter clinical practice. Published in the esteemed journal JACC: Advances, the research employed a vast dataset encompassing nearly 1.7 million patient records from a large integrated healthcare system in the U.S., encompassing both EHR data and 12-lead EKGs. The team’s approach leverages three distinct AI models: one informed solely by EKG waveforms, another utilizing structured EHR inputs comprising more than 150 clinical variables, and a third hybrid model integrating both data sources.

The methodology underpinning the model development was rigorous, stratified across three patient cohorts to ensure robustness and real-world applicability. Initially, the training cohort consisted of 993 out-of-hospital cardiac arrest cases alongside 5,479 age- and sex-matched control subjects without cardiac events, spanning nearly a decade from 2013 to 2021. This comprehensive dataset allowed the AI to discern subtle patterns and predictors embedded in both the electrical signatures of the heart and broader health parameters that correlate with increased SCA risk.

Validation proceeded with a testing cohort from more recent years (2022-2023), which included 463 cardiac arrest incidents and nearly 3,000 controls. Application of the AI models here confirmed their predictive fidelity, with the models reliably distinguishing high- and low-risk profiles congruent with training findings. However, the true test came from applying the tools to a real-world cohort: a large, unfiltered group of nearly 40,000 individuals who had undergone EKG testing in 2021 regardless of pre-existing conditions, followed longitudinally for two years to see who eventually suffered cardiac arrest.

Remarkably, the integrated EHR-EKG AI model correctly identified 153 of the 228 patients who experienced cardiac arrest as high-risk, exhibiting an enrichment in risk prediction that elevated from a baseline of 1 in 1,000 to 1 in 100. This degree of stratification could be transformative in clinical settings, alerting healthcare practitioners and patients alike to a risk magnitude impactful enough to prompt preemptive clinical decisions and potentially lifesaving interventions.

Notably, the EKG-only model – which depends solely on the analysis of the heart’s electrical activity – demonstrated impressive prognostic capability independently, showing only a modest decrease in performance compared to models incorporating the full range of EHR data. Given the global ubiquity and low cost of 12-lead EKG machines, this finding unlocks practical pathways for broad implementation of risk screening even outside advanced healthcare environments.

Beyond cardiovascular parameters traditionally associated with SCA, the AI models illuminated novel risk factors often overlooked in clinical practice. These included electrolyte imbalances, substance use behaviors, and adverse medication interactions, highlighting how multifaceted cardiac arrest triggers can be. This insight suggests that AI-driven risk alerts might encourage clinicians to systematically review modifiable patient factors and perform more nuanced, preventive care tailored to the individual’s comprehensive clinical profile.

Despite this promise, Dr. Chatterjee and his collaborators underscore that predictive power alone is insufficient without clear clinical pathways. The next frontier is refining post-prediction responses: determining which diagnostic tests, monitoring regimens, or therapeutic interventions should follow identification of elevated risk. Clarifying these management strategies is paramount to translating AI prediction into tangible reductions in SCA incidence and mortality.

Another caveat relates to the study’s data source—all drawn from a single healthcare system—raising questions about the generalizability of the models to demographically or geographically distinct populations. Additionally, the real-world cohort limitation to individuals who had undergone EKG testing introduces selection bias; patients not receiving EKGs, who might nonetheless be at risk, remain outside the model’s purview. Furthermore, concerns about AI model biases linked to healthcare disparities and demographic representation warrant careful ongoing evaluation to ensure equitable, unbiased application across diverse patient populations.

The research, funded by prestigious entities including the National Institutes of Health, the American Heart Association, the European Union, and the Foundation Leducq, represents a multi-institutional collaborative success involving Massachusetts General Hospital and the Broad Institute at MIT and Harvard. The confluence of clinical cardiology expertise, data science innovation, and vast patient data has created an unprecedented predictive toolset with the potential to radically change how sudden cardiac arrest is anticipated and perhaps eventually prevented.

Dr. Chatterjee points to an exciting era ahead where artificial intelligence transforms the interpretation of routine medical tests from static snapshots into dynamic, predictive analyses capable of forewarning life-threatening events. This evolution heralds a future in which the frustration and tragedy of sudden cardiac arrest—long an enigmatic killer striking without warning—may become significantly mitigated through enhanced data-driven foresight integrated seamlessly into everyday clinical workflows worldwide.

Subject of Research: People
Article Title: Artificial Intelligence-Enhanced Electrocardiography and Health Records to Predict Cardiac Arrest
News Publication Date: 11-May-2026
Web References: DOI: 10.1016/j.jacadv.2026.102787
Keywords: Cardiac arrest, Artificial intelligence, Electrocardiography, Electronic medical records, Computer modeling

Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, and aging-related changes in the vasculature play an undeniable role in this pervasive health challenge. Historically, assessing cardiovascular risk has relied heavily on traditional factors such as hypertension, cholesterol levels, and lifestyle habits. However, this novel study transcends conventional paradigms by focusing on the heterogeneity of vascular aging manifestations — including arterial stiffness, endothelial dysfunction, and microvascular rarefaction — and clustering these phenotypes to better understand their predictive efficacy.

The research team, led by van Sloten, Boutouyrie, and Abouqateb, conducted an extensive community-based cohort investigation, leveraging advanced imaging techniques combined with longitudinal clinical data to unearth underlying patterns of vascular aging. The researchers employed sophisticated multivariate statistical models and machine learning algorithms to identify natural clusters of vascular phenotypes, thereby capturing the multidimensional nature of vascular health degradation rather than relying on single biomarker assessments.

What makes this approach particularly transformative is its ability to stratify populations into subgroups based on their unique vascular aging profiles, which correlate with varying degrees of cardiovascular event risk. One cluster, characterized by pronounced arterial stiffness together with endothelial impairment, emerged as a high-risk group with significantly elevated incidence rates of myocardial infarction and stroke over the study’s follow-up period. Conversely, clusters exhibiting milder or isolated vascular changes corresponded to comparatively lower event rates.

The vascular aging manifestations that underpinned these clusters are mechanistically diverse, reflecting the complex biology of the aging vascular system. Arterial stiffness, commonly quantified by pulse wave velocity, results from structural alterations within the arterial wall, such as collagen deposition, elastin fragmentation, and smooth muscle cell dysfunction. Endothelial dysfunction, often assessed by flow-mediated dilation techniques, signals impaired vasodilatory capacity and pro-inflammatory states that predispose vessels to atherosclerosis. Microvascular changes detected via retinal imaging and capillary density measurements reveal subtle but critical impairments in tissue perfusion.

The team’s integrative analysis illuminated how these factors do not act in isolation but converge synergistically, compounding the risk. This insight advances the paradigm from a simplistic risk factor tally to a systems-level understanding of cardiovascular aging, emphasizing the need for multiparametric assessments in clinical practice. The implications for personalized medicine are profound: by identifying individuals who fall into these high-risk vascular aging clusters early, clinicians could tailor preventive strategies more effectively, targeting specific vascular dysfunction pathways rather than generic guidelines.

Furthermore, the study’s design incorporated robust longitudinal follow-up and external validation cohorts, ensuring the reproducibility and generalizability of findings. The researchers meticulously controlled for confounding factors such as demographic variables, comorbid conditions, and medication use, strengthening the evidence that vascular aging clusters independently predict cardiovascular events. By leveraging modern computational methodologies alongside state-of-the-art vascular imaging, this work bridges the gap between molecular vascular biology and epidemiological risk prediction.

The findings also subtly underscore potential therapeutic targets. For instance, interventions aimed at reducing arterial stiffness—whether through pharmacologic agents like ACE inhibitors or lifestyle modifications such as structured exercise—could profoundly shift a patient’s cluster designation and consequently their risk trajectory. Similarly, therapeutics enhancing endothelial function may be pivotal in altering disease course for certain vascular aging phenotypes identified in the clusters.

Beyond clinical implications, this research stimulates new avenues for basic science inquiry into the biological underpinnings of vascular aging clusters. Molecular profiling of individuals within each cluster could reveal distinct gene expression patterns, inflammatory mediators, and extracellular matrix remodeling factors. Such discoveries would refine our mechanistic understanding of cardiovascular aging and accelerate the development of biomarker-driven therapies.

Critically, this work drives home the notion that cardiovascular aging is not monolithic but a composite of overlapping vascular pathophysiologies. This nuanced appreciation invites a reassessment of current cardiovascular risk models, which, though robust, often fail to capture the dynamic, multifaceted nature of vascular aging. Incorporation of cluster-based vascular aging assessments in future risk calculators could enhance predictive accuracy, ultimately saving lives through earlier detection and intervention.

The study’s dissemination has sparked rapid discourse among cardiologists, gerontologists, and preventive medicine experts worldwide. Many see the cluster approach as a potential blueprint for investigating other age-related conditions characterized by heterogeneity, such as neurodegenerative diseases and metabolic syndromes. Moreover, the computational framework applied herein exemplifies the transformative potential of artificial intelligence and machine learning in medical research, turning vast complex datasets into actionable clinical insights.

While the findings are undeniably promising, some challenges remain in translating these vascular aging clusters into routine clinical practice. Standardization of measurement techniques, scaling of sophisticated imaging modalities, and integration into electronic health records will require concerted efforts across healthcare systems. Furthermore, it will be essential to validate cluster-based interventions prospectively through randomized clinical trials before widespread adoption.

Despite these hurdles, the study by van Sloten and colleagues represents a quantum leap forward in cardiovascular epidemiology and precision health. By decoding the complex signatures of vascular aging within community populations, they have charted a novel pathway toward individualized risk prediction and tailored therapeutics. This research not only illuminates the hidden landscape of vascular aging but also charts a course toward healthier aging for millions globally.

In summary, the identification of distinct vascular aging clusters as robust predictors of incident cardiovascular events heralds a new era in cardiovascular medicine. Combining cutting-edge vascular phenotyping, advanced data analytics, and community-based cohort research, this landmark study challenges conventional risk assessment paradigms. It sets the stage for transforming how clinicians assess cardiovascular risk and personalize care based on nuanced vascular health signatures. Going forward, the integration of cluster-derived insights with emerging molecular and clinical data has the potential to revolutionize cardiovascular prevention and treatment on a global scale.

Van Sloten et al.’s contribution represents a beacon of hope in the quest to mitigate the global burden of cardiovascular disease through innovative science and patient-centered care. As the population ages and cardiovascular challenges intensify, the promise of cluster-based vascular aging evaluation holds the key to unlocking proactive strategies that preserve vascular integrity and extend healthy lifespans.

Subject of Research: Clusters of vascular aging manifestations and their role in predicting cardiovascular events in community populations.

Article Title: Clusters of vascular aging manifestations predict incident cardiovascular events in the community.

Article References:
van Sloten, T., Boutouyrie, P., Abouqateb, M. et al. Clusters of vascular aging manifestations predict incident cardiovascular events in the community. Nat Commun (2026). https://doi.org/10.1038/s41467-026-70137-4

Image Credits: AI Generated

The study elaborates on the necessity of dataset size for training segmentation models, emphasizing how large and diverse datasets can significantly improve algorithm performance. By providing ample examples, including various coronary artery anatomies and pathologies, models can learn to generalize better, leading to more reliable outcomes in real-world applications. This finding is particularly pertinent as medical imaging datasets are often limited, which can hamper the development of effective machine-learning algorithms.

Windowing techniques emerge as pivotal tools in the segmentation process. Hung et al. systematically analyze different windowing methods that affect image input to neural networks, exploring how variations can lead to differing segmentation success rates. The research underscores the need for optimal window settings to capture essential features while minimizing irrelevant information that can lead to confusion within the algorithms. This meticulous attention to detail in preprocessing allows for a more effective model, capable of handling the complexities of coronary artery shapes and sizes.

The exploration of various model architectures showcases the potential of deep learning in medical imaging. The researchers compare traditional models with more advanced deep learning architectures, revealing that newer neural networks often outperform their predecessors. By diving into the specifics of each architecture, including convolutional neural networks and innovative variants, the study highlights how these systems can be tailored to improve segmentation efficacy. This is a significant advantage for practitioners who rely on these technologies for diagnostic procedures.

Vessel geometry emerges as another critical component in segmentation. The unique shapes and branching patterns of coronary arteries pose challenges for segmentation algorithms. The researchers delve into how understanding these geometric properties can lead to more accurate modeling of vascular structures. By analyzing the relationships between artery size, branch points, and overall vessel trajectories, the findings advocate for algorithms designed with these geometrical considerations in mind.

Moreover, the findings of this research have broader implications for the use of artificial intelligence in healthcare. With the advancement of machine learning and computer vision, there is a potential for real-time, automated segmentation, paving the way for faster diagnostics and interventions. The enthusiasm surrounding AI’s capacity to assist medical professionals in interpreting imaging data has never been higher, but as this research shows, the groundwork must be meticulously laid for these technologies to reach their full potential.

In addition, Hung et al.’s work is a clarion call for collaboration across disciplines. The intersection of engineering, computer science, and medicine has emerged as a powerhouse for innovation, and the authors advocate for continued interdisciplinary partnerships. By leveraging the expertise of various fields, the development of robust segmentation algorithms can be accelerated, ensuring they meet the needs of medical practitioners and patients alike.

An important consideration is the balance between computational efficiency and accuracy. This research underscores the necessity for segmentation algorithms to not only perform well but to do so within reasonable timeframes. This is particularly critical in clinical environments where time is often of the essence. The ability to swiftly and accurately segment coronary arteries could lead to more timely interventions, ultimately saving lives.

As researchers dig deeper into the nuances of coronary artery segmentation, they also raise important questions about the validation of segmentation algorithms. The need for rigorous testing against clinical standards is paramount. The authors push for comprehensive validation studies to ensure these algorithms’ reliability and applicability in real clinical settings. Without extensive validation, even the most sophisticated algorithms risk being ineffective in life-saving situations.

The research by Hung et al. serves as a comprehensive guide, offering design rules for those interested in developing and refining coronary artery segmentation algorithms. Their systematic analysis provides a roadmap for future work in the field, ensuring that subsequent studies build upon these foundational principles. This work not only contributes to the domain of medical imaging but also sets a precedent for rigorous scientific inquiry in applied machine learning.

Looking ahead, the potential applications of this research extend beyond coronary artery segmentation. As the methodologies for robust segmentation become established, similar processes can be adapted for other vascular structures and possibly for different organ systems. This adaptability amplifies the significance of the research, as it opens up avenues for improving medical imaging technologies across the board.

In summary, the work of Hung et al. represents a significant leap forward in the realm of coronary artery segmentation. By systematically analyzing the interplay of dataset size, windowing, architectures, and vessel geometry, they collectively pave the way for more refined and reliable algorithms. As the healthcare landscape continues to evolve, their findings will undoubtedly resonate within the future of medical imaging and artificial intelligence in healthcare.

As researchers continue to refine these techniques, the hope is that they will translate into tangible benefits for patient care. With cardiovascular diseases being the leading cause of death worldwide, the importance of accurate coronary artery segmentation cannot be overstated. Through continued research and innovation in this field, we move closer to improving patient outcomes and advancing the role of technology in healthcare.

Subject of Research: Coronary artery segmentation

Article Title: Design Rules for Robust Coronary Artery Segmentation: A Systematic Analysis of Dataset Size, Windowing, Architectures, and Vessel Geometry

Article References: Hung, MH., Chiang, YW., Liu, HY. et al. Design Rules for Robust Coronary Artery Segmentation: A Systematic Analysis of Dataset Size, Windowing, Architectures, and Vessel Geometry. Ann Biomed Eng (2026). https://doi.org/10.1007/s10439-026-03974-5

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s10439-026-03974-5

Keywords: Coronary artery segmentation, dataset size, windowing, model architectures, vessel geometry, deep learning, medical imaging, artificial intelligence

The advent of machine learning has transformed numerous fields, yet its integration into medical diagnostics often lags behind. This study addresses that gap directly by presenting a unique model tailored for RVD identification. The LogNNet model, distinguished by its logarithmic framework, leverages non-linear relationships in complex datasets. This characteristic allows the diagnostic tool to discern subtle patterns in cardiological data that may escape conventional methods, challenging the status quo in cardiovascular diagnostics.

RVD, an often silent yet dangerous condition, can lead to significant morbidity and mortality if left undetected. While classical echocardiography has been the gold standard for diagnosing ventricular issues, its efficacy is limited by the operator’s experience and the variability of interpretations. The new model developed by Huyut and his team promises to alleviate these challenges. By implementing advanced machine learning techniques, the research aims to reduce diagnostic discrepancies and enhance the reliability of RVD assessment.

The study intricately portrays the architecture of the LogNNet model, outlining how its design enables it to adaptively learn from pre-labeled cardiac data. Unlike conventional algorithms, which often rely on rigid structures, LogNNet evolves through its training phases. This adaptability ensures that it not only identifies the present data patterns but can also anticipate emerging trends, a critical factor in the dynamic nature of cardiac conditions.

To validate the efficacy of their model, the researchers conducted extensive comparisons with other well-established supervised machine learning algorithms. These comparisons are essential to gauge the strengths and weaknesses of the LogNNet framework against competitors like support vector machines and random forests. Initial results illustrate that LogNNet significantly outperforms these traditional methods, particularly in environments with complex data distributions that are characteristic of cardiac imaging.

Moreover, the dataset leveraged in this transformative study was not only vast but also richly diverse. Emphasizing the importance of a comprehensive training set, the research team utilized data gathered from multiple clinical sites, providing a robust cross-section of RVD presentations across various demographics. This breadth of data underpins the model’s ability to generalize to a wide array of patient populations, aiming to eliminate biases that often skew diagnostic accuracy in smaller, less diverse datasets.

As the research unfolded, the implications for patient care surfaced as a critical focus. With an enhanced diagnostic tool at their disposal, clinicians may soon deliver quicker and more accurate interventions for patients suffering from RVD. The potential interactive feedback loop described by the authors signifies a monumental shift in patient management strategies. More nuanced understanding of right ventricular function can foster individualized treatment plans, tailored to the unique presentations seen in each patient.

In addition, the authors articulated the potential for further extension into other cardiovascular domains. The methodologies utilized and discoveries made within this study can inspire a new wave of research aimed at other forms of heart dysfunction. The adaptability of the LogNNet model may lead to similar tools for addressing left ventricular dysfunction or even broader ischemic heart diseases, thus offering a multitude of novel insights into cardiology.

With technological advancements often raising ethical questions within the medical community, the authors took a moment to discuss the implications of their work. The advent of machine learning in diagnostics necessitates informed discussions around bias, data integrity, and transparency in algorithmic decision-making. The researchers emphasize the significance of continuous monitoring and evaluation of machine learning tools in healthcare, advocating for rigorous standards that prioritize patient outcomes.

Looking forward, the researchers envision a collaborative landscape where machine learning and traditional cardiology coalesce to optimize patient care. The synergy between these two realms could potentially redefine how healthcare practitioners approach diagnosis and treatment, nudging professionals towards a more data-driven model while preserving the invaluable human aspect of medicine.

The paper concludes with a call to action for further research and cross-disciplinary collaboration. By pooling resources, expertise, and insights from diverse fields, the evolution of medical diagnostics can move expeditiously towards incorporating machine learning advancements. Ultimately, this collective effort could empower clinicians worldwide to better recognize and address right ventricular dysfunction, fundamentally reshaping cardiac care protocols for future generations.

In summary, the study led by Huyut and his colleagues signifies a watershed moment in cardiology. By challenging existing paradigms with innovative machine learning approaches, they have opened doors to a future where diagnostic accuracy and efficiency may no longer be dependent solely on human interpretation. With research efforts like this, the medical community can look ahead with optimism, ready to embrace a transformative era in patient care.

Subject of Research: Right ventricular dysfunction and machine learning diagnostics.

Article Title: Author Correction: Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.

Article References:

Huyut, M.T., Velichko, A., Belyaev, M. et al. Author Correction: Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.
Sci Rep 15, 44430 (2025). https://doi.org/10.1038/s41598-025-33278-y

Image Credits: AI Generated

DOI: 10.1038/s41598-025-33278-y

Keywords: Machine Learning, Right Ventricular Dysfunction, LogNNet, Cardiology, Diagnostics, Supervised Algorithms, Patient Care, Data Science.

The key advancement introduced in this study is the assignment of calibrated numeric probabilities to the algorithm’s assessments. Previously, the algorithm’s output included broad categorizations like “suspected HCM” or “high risk of HCM.” However, researchers at Mount Sinai have refined the process to give patients more concrete information—such as a specific likelihood of having HCM, which could, for example, indicate a 60% chance of the condition. Joshua Lampert, MD, who is the Director of Machine Learning at Mount Sinai Fuster Heart Hospital, emphasized the transformative potential of this detailed feedback for patients. It allows individuals who might not have been previously diagnosed with HCM to gain insights into their heart health, thereby facilitating early intervention and treatment.

The importance of such advancements cannot be overstated, especially considering that HCM affects approximately one in 200 people worldwide and remains one of the leading causes for heart transplantation. Many individuals with HCM are unaware they have the condition until symptoms arise, often when the disease has already progressed to a more severe stage. By integrating this AI tool into clinical workflows, doctors can identify high-risk individuals earlier, potentially preventing critical complications associated with HCM, such as sudden cardiac death—particularly affecting younger patients, who are often in the prime of their lives.

The research team under Lampert analyzed nearly 71,000 ECG readings collected from patients between March 2023 and January 2024. Out of these, the Viz HCM algorithm flagged 1,522 cases as showing potential signs of HCM. To validate the findings, researchers conducted an extensive review of patient records and imaging data to establish confirmed diagnoses of HCM. The results yielded promising conclusions: the calibrated AI model effectively provided an accurate correlation between its predicted probabilities of HCM and the actual incidence of the disease among patients.

Enhancing the interpretability of AI in healthcare has become a major focus in recent years, and this study serves as a prime example of how technology can be integrated into clinical practices to improve patient care. Clinicians can leverage this calibrated risk model to prioritize patients according to their individual levels of risk, ultimately streamlining clinical workflows. This change allows healthcare providers to offer more tailored guidance during consultations, transforming how patients experience the healthcare system.

Dr. Vivek Reddy, co-senior author and Director of Cardiac Arrhythmia Services for Mount Sinai Health System, remarked on the transformative potential of these developments in clinical practice. He noted that the utilization of novel algorithms like Viz HCM could significantly enhance patient triage and risk stratification processes. This methodological sophistication underscores the increasing importance of employing advanced AI tools not just for their performance but for their capacity to improve patient outcomes and align with existing clinical practices.

In addition to enhancing patient care through a clearer understanding of individual risks, the research also emphasizes the importance of pragmatic implementation in healthcare settings. Dr. Girish N. Nadkarni, another co-senior author and Chair of the Windreich Department of Artificial Intelligence and Human Health, highlighted that successful integration of AI into medical workflows hinges on its ability to support clinical decision-making while ensuring it aligns with how healthcare is delivered. This study exemplifies a responsible approach to the integration of AI, showcasing that a calibrated model can significantly aid clinicians in managing their patient populations more effectively.

Despite the promising outcomes of this study, the research team acknowledges that further exploration is required for the broader application of this AI calibration strategy across different health systems nationwide. The next phase of research will focus on expanding the use of the calibrated model to ensure its efficacy and adaptability across diverse clinical environments. The ultimate goal is to establish a standardized method for employing AI technology and machine learning algorithms to enhance the predictability and reliability of cardiac diagnoses.

The potential implications of this study extend beyond the realm of HCM, as they pave the way for implementing AI in addressing a wide variety of conditions. As advancements continue within the AI space, cardiologists and healthcare providers are encouraged to remain vigilant and informed about the technological innovations that can be utilized to enhance patient care.

As the healthcare landscape navigates the integration of innovative AI tools, it becomes increasingly critical for medical practitioners to embrace these changes for the benefit of their patients. With the ability to provide targeted risk assessments and improved clinical workflow efficiency, the use of calibrated AI models represents a significant leap forward in the medical field. Researchers and clinicians are hopeful that this will establish a new paradigm in cardiology and beyond, effectively revolutionizing how patients are diagnosed, treated, and monitored.

The Mount Sinai Health System, renowned for its commitment to exceptional cardiovascular care, holds a pivotal role in championing such initiatives. As collaborative efforts among researchers, healthcare professionals, and technology developers continue to flourish, the mounting evidence supporting the role of AI in enhancing accuracy, efficiency, and patient engagement in healthcare will undoubtedly continue to grow.

Subject of Research: Hypertrophic cardiomyopathy (HCM) detection using AI.
Article Title: Calibration of ECG-Based Deep Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy.
News Publication Date: April 22, 2025.
Web References: https://www.mountsinai.org/
References: NEJM AI, 2025.
Image Credits: Reproduced with permission from NEJM AI, Lampert, 2025. Copyright 2025 Massachusetts Medical Society.

Keywords

Artificial intelligence, Hospitals, Human health, Heart disease, Risk factors, Machine tools, Cardiology, Cardiomyopathy, Electrocardiography.

The concept of biological age, often defined as the functional age of an individual’s organs relative to their chronological age, places significant emphasis on the health status of the heart as it can vary widely among individuals of the same age. For instance, a 50-year-old with optimal heart health may exhibit a biological heart age of 40, while another individual of the same age with significant cardiovascular issues could have a biological heart age of 60. This distinction is instrumental in understanding individual predispositions to cardiovascular events and mortality risk.

Researchers utilized advanced machine learning techniques to develop an algorithm capable of predicting biological heart age. Associate Professor Yong-Soo Baek of Inha University Hospital in South Korea highlighted that their study’s findings indicate that when biological heart age exceeds chronological age by seven years, the risk of all-cause mortality and major adverse cardiovascular events (MACE) escalates significantly. Notably, the algorithm also revealed that a biological heart age that is seven years younger than chronological age is associated with a decreased risk of these adverse outcomes, underscoring the importance of heart health beyond mere chronological markers.

The study analyzed a vast dataset of 425,051 standard 12-lead ECGs collected over a period of fifteen years. A deep learning model was trained to assess ECG features that inform biological heart age, comparing these findings against traditional assessments determined by chronological age. The subsequent results were validated against a separate cohort of 97,058 ECGs, demonstrating the robustness of the algorithm and its potential to predict mortality and cardiovascular health risks accurately.

Statistical analyses revealed alarming correlations that could reshape cardiovascular risk assessments. An AI-derived biological heart age exceeding the individual’s chronological age by seven years was linked to a striking 62% increase in the risk of all-cause mortality and a staggering 92% rise in the risk of MACE. On the flip side, an AI biological heart age seven years younger than chronological age corresponded with a 14% reduction in all-cause mortality and a 27% decrease in MACE risk.

An important aspect of the study is its findings concerning the ejection fraction, a key measure of heart function that indicates how well the heart pumps blood. The results consistently indicated that subjects with reduced ejection fractions exhibited higher AI biological heart ages in conjunction with prolonged QRS durations and corrected QT intervals. These metrics, indicative of the heart’s electrical signaling and its overall health, suggest deep underlying cardiac conditions that the AI algorithm may effectively monitor.

The implications of these findings extend far beyond academic research. The integration of AI in cardiovascular assessment signifies a transformative shift in how clinicians may approach patient evaluations. The ability to utilize AI-driven insights to refine cardiac health assessments has the potential to streamline patient management strategies in clinical settings, allowing healthcare providers to identify high-risk patients for early intervention.

Furthermore, the correlation established between AI biological heart age and other cardiac parameters reflects the need for continued exploration into the intricacies of heart health. The researchers emphasize that obtaining larger and more statistically significant samples in future studies will be critical for validating these findings further, enhancing the applicability of their algorithm in real-world clinical practice.

The value of an AI-driven approach in predicting heart age and related risks shines a light on the future of personalized medicine. Tailoring cardiovascular risk assessments to the biological age of the heart rather than solely relying on chronological age can usher in a new era of preventative cardiovascular care, potentially saving countless lives by prioritizing early detection and intervention strategies for those at risk.

In conclusion, the revolutionary potential of this AI-based algorithm indicates a significant step forward in cardiovascular health assessment. As healthcare continues to evolve, the insights derived from this technology could refine how clinicians assess heart health, ensuring that individuals receive appropriate care based on their unique physiological status rather than merely their age. This study heralds a promising future for integrating artificial intelligence into healthcare to not only understand but also improve cardiovascular health outcomes on a population scale.

Subject of Research: AI-Based Algorithm for Predicting Biological Heart Age
Article Title: Novel AI Algorithm Predicts Biological Heart Age, Enhancing Cardiovascular Risk Assessment
News Publication Date: 31 March 2025
Web References: ESC Press Office
References: Not applicable
Image Credits: Not applicable

Keywords: AI, biological heart age, cardiovascular health, ECG, predictive analytics, ejection fraction, machine learning, cardiovascular risk assessment

Electrocardiograms have long been a critical tool in clinical medicine, allowing healthcare professionals to monitor heart health and gain valuable insights into cardiovascular functioning. However, the interpretation of ECG data is no simple task. Accurately analyzing these readings often necessitates extensive medical knowledge, making the process both resource-intensive and prone to error. In environments where trained cardiologists are scarce, the manual interpretation of ECG readings can be slow and fraught with the potential for misdiagnosis.

Despite considerable progress in recent years, particularly with the application of deep learning techniques, a pressing need remains for more integrated models capable of analyzing ECG data along with patient information in tandem. This gap is precisely where the ECG-LM model sets itself apart, as it seamlessly combines state-of-the-art machine learning with LLMs to bridge this existing divide. The researchers have taken a bold step forward, combining deep learning methodologies with advanced language processing to enhance ECG interpretation.

The ECG-LM framework developed by the Tsinghua University research team represents a significant advancement in utilizing artificial intelligence within healthcare. By integrating the capabilities of LLMs, the ECG-LM model interprets ECG data in conjunction with vital patient-specific information, which includes medical history, presenting symptoms, and other relevant data. This multilayered approach facilitates more accurate and contextually nuanced diagnoses of various heart conditions, transforming how ECG data is utilized in clinical practice.

Delving into the intricacies of their model, the researchers employed deep learning techniques to develop a system capable of identifying subtle ECG patterns that traditional analysis methods might overlook. The extensive dataset utilized for training the model contained numerous ECG readings correlated with comprehensive clinical data. By identifying associations between the ECG signals and broader health trends, the ECG-LM model demonstrates an enhanced capacity to detect arrhythmias, heart attacks, and other cardiovascular issues, even in their earliest stages when symptoms may be minimal or nonexistent.

Through extensive clinical testing, the ECG-LM system has showcased considerable enhancements relative to conventional diagnostic tools. The model exhibited remarkable efficiency, processing ECG readings with increased speed and accuracy, while also generating probable diagnoses drawn from a multitude of patient data sources. The researchers’ rigorous evaluations indicate that ECG-LM not only outperforms traditional models in precision but also presents essential advantages in terms of operational efficiency, positioning it as a critical asset for healthcare practitioners, especially in high-volume or resource-limited settings.

Dr. Zaiqing Nie, the lead researcher at Tsinghua University, highlighted the broader implications of their findings, noting that this research marks a pivotal moment in cardiovascular medicine. By harnessing the capabilities of large language models, the team aims to accelerate the ECG interpretation process, making it faster and more reliable. Dr. Nie emphasized the potential impact on global healthcare, stating that improved diagnostic capabilities could save innumerable lives by providing timely and accurate assessments in a field that often deals with life-threatening conditions.

One of the most revolutionary aspects of the ECG-LM model is its potential to democratize advanced heart disease diagnostics, particularly in underserved regions that lack specialized medical personnel. By automating substantial portions of the diagnostic process, healthcare providers can devote more attention to direct patient care, ultimately fostering better health outcomes for individuals suffering from cardiovascular conditions. Such advancements stand to benefit global health significantly, particularly in areas where medical resources are constrained.

As promising as the ECG-LM model is, the research team recognizes that their work is merely the beginning. They plan to refine the model further by integrating additional data sources and enhancing its interpretability. The aim is to develop an even more user-friendly system for clinicians, ensuring that the technology can be seamlessly incorporated into existing healthcare workflows and addressing a wide range of healthcare applications beyond cardiology.

Collaboration represents another avenue of exploration for the researchers as they seek out partnerships with hospitals and healthcare providers interested in testing the ECG-LM system in real-world clinical environments. Ensuring that the model is primed for widespread deployment is a critical aspect of their future work. Dr. Nie explained that their efforts will concentrate on enhancing the model’s adaptability and interpretability, solidifying its status as an essential tool for medical practitioners in the field.

With the introduction of the ECG-LM model, Tsinghua University and Beijing Tsinghua Changgung Hospital are poised at the forefront of a transformative era in cardiovascular diagnostics. By leveraging the capabilities of large language models, these researchers are not only reimagining how ECG data is understood but also paving the way for significant advancements in clinical settings. Improved diagnostic accuracy, speed, and accessibility are now within reach, showcasing the incredible potential of AI within healthcare.

As the landscape of medical diagnostics continues to evolve, the ECG-LM model exemplifies a promising pathway for further advancements in electrocardiography and other areas of healthcare. The outcomes of this research serve as an inspirational blueprint for future innovations, demonstrating the substantial impact that interdisciplinary collaboration can have in tackling complex medical challenges and improving patient outcomes across the globe.

The excitement surrounding the ECG-LM model encapsulates a vision for the future of cardiovascular health, where smart, AI-driven tools become indispensable allies for healthcare professionals. With ongoing research and focus on refinement and collaboration, the path forward looks bright for ECG-LM and the critical radii of healthcare it seeks to serve.

By intertwining AI advancements with medical expertise, this research advances not only our understanding of ECG but also highlights the importance of innovative solutions in meeting the challenges of contemporary healthcare. The ECG-LM model is poised to serve as a vital resource in the medical field, ensuring the delivery of timely and accurate diagnoses that could save lives and redefine patient care for those at risk of cardiovascular diseases.

Subject of Research: ECG Data Interpretation Using Large Language Models
Article Title: ECG-LM: Understanding Electrocardiogram with a Large Language Model
News Publication Date: 4-Feb-2025
Web References: http://dx.doi.org/10.34133/hds.0221
References: Health Data Science
Image Credits: Zaiqing Nie, Institute for AI Industry Research (AIR), Tsinghua University

Keywords: Electrocardiography, Cardiovascular Diagnostics, Artificial Intelligence, Deep Learning, Medical Technology.

• Respiratory and infection
• Personalised cancer prevention and treatment
• Lifestyle (including diabetes)
• Environment and health
• Data innovation for multiple long term health conditions and ethnic health
• Cardiovascular disease

The BRC harnesses the power of experimental science to explore and develop ways to help prevent and treat chronic disease. It brings together 120 highly skilled researchers, 45 academic ‘rising stars’, more than 90 support staff and students and over 450 public contributors. By having scientists working closely with clinicians and the public, the BRC can deliver research that is relevant to both patients and the professionals who treat them. www.leicesterbrc.nihr.ac.uk     The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:

• Funding high quality, timely research that benefits the NHS, public health and social care;
• Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
• Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
• Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
• Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
• Funding applied global health research and training to meet the needs of the poorest people in low and middle income countries.

NIHR is funded by the Department of Health and Social Care. Its work in low and middle income countries is principally funded through UK Aid from the UK government.
Leicester’s Research Registry was launch in May 2021 and will share opportunities to get involved in health research taking place in Leicester’s Hospitals, or being run with their research partners, such as the University of Leicester and Loughborough University, in their National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Clinical Research Facility and Patient Recruitment Centre: Leicester.   To sign up to the registry, potential volunteers need to be over 18 years of age, live in the UK, and have a valid email address. You also have the option to select if there are particular areas of health research you are interested in. You will then receive regular updates on all the exciting opportunities to participate in the hospitals’ research.
To sign up, visit www.leicestershospitals.nhs.uk/researchregistry. You can also visit the dedicated Facebook page.

Journal

European Heart Journal

Method of Research

Computational simulation/modeling

Subject of Research

People

Article Title

Artificial intelligence for ventricular arrhythmia capability using ambulatory electrocardiograms

Article Publication Date

30-Jan-2024

COI Statement

none declared